Editorial (Thematic Issues: Therapeutic Strategies to Target Endothelial Nitric-Oxide Synthase (eNOS))

E-ISSN： 1873-4286|20|22|3501-3502

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.22, 2014-05, pp. : 3501-3502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Relationship Between Inflammation and the Anticoagulant Pathway: The Emerging Role of Endothelial Nitric Oxide Synthase (eNOS)

Current Pharmaceutical Design, Vol. 10, Iss. 8, 2004-03 ,pp. : 923-927

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide Synthase (NOS) as Therapeutic Target for Asthma and Chronic Obstructive Pulmonary Disease

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 721-735

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide: Target for Therapeutic Strategies in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2837-2850

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism

By Wattanapitayakul S.K. Mihm M.J. Young A.P. Bauer J.A.

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 361-368

Elsevier

Access to resources Recommend Favorite

Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents

Current Cancer Drug Targets, Vol. 7, Iss. 5, 2007-08 ,pp. : 475-483

Bentham Science Publishers

Access to resources Recommend Favorite